Collecting and studying samples in cardiac sarcoidosis
Part of Heart & circulation, Immune system & allergy clinical trials.
This study collects and analyzes blood or tissue samples from people with cardiac sarcoidosis or inflammatory cardiomyopathy to better understand these conditions. The goal is to improve diagnosis and treatment, which may help manage heart failure and arrhythmias.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have or are suspected to have cardiac sarcoidosis or inflammatory cardiomyopathy, based on symptoms, imaging (MRI or PET-CT), or need for advanced heart support.
- You have provided written informed consent to participate and allow analysis of your blood or tissue samples.
- You do not have a psychiatric illness that would impair your ability to understand or consent.
- Your heart failure is not mainly due to coronary artery disease (blocked arteries) or heart valve disease.
- You do not have another severe illness that would likely lead to death within one year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how doctors can best tell whether someone has cardiac sarcoidosis, a condition where inflammation affects the heart. It may help you get a more accurate diagnosis using expert guidelines and special heart tests, and it groups patients as proven, probable, or unlikely.
This study follows people with sarcoidosis that may or may not be affecting the heart. It uses special scans (PET and MRI) to look for heart involvement and track how the disease changes over time.
This trial studies a treatment approach for people with active cardiac sarcoidosis, confirmed by specific heart rhythm/heart function problems and a PET scan. It may help by targeting the active inflammation driving heart conduction problems, rhythm events, or weak heart pumping.
This study looks for disease markers in tiny particles called exosomes in your blood to better understand cardiac sarcoidosis (a condition where inflammation affects the heart). By measuring these markers alongside your standard heart imaging, researchers hope to find better ways to detect and monitor the disease.
This study checks whether a special heart scan called PET/MRI can predict how sarcoidosis may affect your heart. It may help doctors better estimate heart risk and plan follow-up based on scan findings.
This trial tests if rilonacept can help people with cardiac sarcoidosis, a condition where inflammation affects the heart. You may join if you have active inflammation on a PET scan despite standard treatments.
Hear when a new Cardiac Sarcoidosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.